Better resolving of anti‐CD38 antibody interference with blood compatibility testing by using manual polybrene method compared with dithiothreitol‐pretreatment indirect antiglobulin test
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Chiu-Che Feng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Hexadimethrine Bromide, Hematologic Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
It is advised to pretreat the reagent erythrocytes with Dithiothreitol (DTT) to denature the surface CD38 to prevent anti‐CD38 monoclonal antibodies (MoAb) from interfering with the blood compatibility test. Anti‐CD38 has little impact on the Polybrene test, but it is still unknown how sensitive it is to detect irregular antibodies and how effective it is when compared to the standard DTT‐based method.
Methods
Twenty‐one patients receiving daratumumab ( N = 13) and isatuximab ( N = 8) had their serum collected. Standard anti‐sera (anti‐c, D, E, Fy b , Jk a , M, Mi a ) with serial dilution were added to patients' serum. Antibody screening tests were performed simultaneously using the manual polybrene method (MP) and DTT‐pretreated, automatic indirect antiglobulin test (DTT‐IAT) to compare the detection sensitivity. These two methods' operating times and costs were also analyzed.
Results
Both MP and DTT‐IAT can overcome the interference caused by anti‐CD38 MoAb. However, MP is more sensitive in detecting anti‐M and anti‐Mi a and is comparable to DTT‐IAT in detecting other antibodies. In terms of cost and operating time, MP is also far superior to DTT‐IAT.
Conclusion
MP is a cost‐effective alternative to DTT‐IAT in resolving anti‐CD38 interference and is especially suitable for populations with a high prevalence of anti‐M and anti‐Mi a . However, both methods have a well‐known drawback of low detection sensitivity for anti‐K, and K‐units should be provided to patients to prevent hemolytic transfusion reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
- Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Blood Bank, Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan.
- Transfusion Committee, China Medical University Hospital, Taichung, Taiwan.
- College of Medicine, China Medical University, Taichung, Taiwan.
ORCID-Profile: Su-Peng Yeh
Zitieren
APA
Feng, C. C., Chang, C. W., Lien, Z. Y., Lin, J. A., Chen, T. T., & Yeh, S. P. (2023). Better resolving of anti‐CD38 antibody interference with blood compatibility testing by using manual polybrene method compared with dithiothreitol‐pretreatment indirect antiglobulin test. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24891
Vancouver
Feng CC, Chang CW, Lien ZY, Lin JA, Chen TT, Yeh SP. Better resolving of anti‐CD38 antibody interference with blood compatibility testing by using manual polybrene method compared with dithiothreitol‐pretreatment indirect antiglobulin test. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24891
BibTeX
@article{Feng2023,
author = {Feng, Chiu-Che and Chang, Ci-Wen and Lien, Zhi-Yi and Lin, Jinun-An and Chen, Tzu-Ting and Yeh, Su-Peng},
title = {Better resolving of anti‐CD38 antibody interference with blood compatibility testing by using manual polybrene method compared with dithiothreitol‐pretreatment indirect antiglobulin test},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24891}
}
EUVIMED